Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Wouter Jukema

Showing results (31-40 of 927) with videos related to

Pageof 93
Sort By:
Liver International : Official Journal of the International Association for the Study of the Liver|November 27, 2023
Assessment of myocardial dysfunction in cirrhotic patients: Should we look at the left atrium rather than at the left ventricle?Roos A Groen, Nina Ajmone Marsan, J Wouter Jukema, et al.
Postgraduate Medical Journal|June 26, 2012
Republished: How to reduce sudden cardiac death in patients with renal failureMihály K de Bie, Maurits S Buiten, Ton J Rabelink, et al.
BMC Genetics|January 29, 2008
Estimating effects of rare haplotypes on failure time using a penalized Cox proportional hazards regression modelOlga W Souverein, Aeilko H Zwinderman, J Wouter Jukema, et al.
Heart (British Cardiac Society)|January 24, 2012
How to reduce sudden cardiac death in patients with renal failureMihály K de Bie, Maurits S Buiten, Ton J Rabelink, et al.
Nature Reviews. Cardiology|July 13, 2021
Effects of fatty acids on T cell function: role in atherosclerosisNathalie A Reilly, Esther Lutgens, Johan Kuiper, et al.
Clinical Science (London, England : 1979)|February 15, 2005
Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical eventsMaaike K Hofman, Hans M G Princen, Aeilko H Zwinderman, et al.
Biomarkers in Medicine|February 3, 2012
Future potential biomarkers for postinterventional restenosis and accelerated atherosclerosisJacco C Karper, Mark M Ewing, J Wouter Jukema, et al.
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|June 11, 2015
Blood Leukocyte Count on Admission Predicts Cardiovascular Events in Patients with Acute Non-ST Elevation Myocardial InfarctionSurya Dharma, Rosmarini Hapsari, Bambang B Siswanto, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 7, 2007
The current status of multislice computed tomography in the diagnosis and prognosis of coronary artery diseaseJoanne D Schuijf, J Wouter Jukema, Ernest E van der Wall, et al.
Mayo Clinic Proceedings|January 7, 2020
Renal Impairment, Cardiovascular Disease, and the Short-Term Efficacy and Safety of PCSK9 Targeted by InclisiranLaurien E Zijlstra, Stella Trompet, Simon P Mooijaart, et al.
Pageof 93

Showing results (31-40 of 927) with videos related to

Sort By:
Pageof 93
Liver International : Official Journal of the International Association for the Study of the Liver|November 27, 2023
Assessment of myocardial dysfunction in cirrhotic patients: Should we look at the left atrium rather than at the left ventricle?Roos A Groen, Nina Ajmone Marsan, J Wouter Jukema, et al.
Postgraduate Medical Journal|June 26, 2012
Republished: How to reduce sudden cardiac death in patients with renal failureMihály K de Bie, Maurits S Buiten, Ton J Rabelink, et al.
BMC Genetics|January 29, 2008
Estimating effects of rare haplotypes on failure time using a penalized Cox proportional hazards regression modelOlga W Souverein, Aeilko H Zwinderman, J Wouter Jukema, et al.
Heart (British Cardiac Society)|January 24, 2012
How to reduce sudden cardiac death in patients with renal failureMihály K de Bie, Maurits S Buiten, Ton J Rabelink, et al.
Nature Reviews. Cardiology|July 13, 2021
Effects of fatty acids on T cell function: role in atherosclerosisNathalie A Reilly, Esther Lutgens, Johan Kuiper, et al.
Clinical Science (London, England : 1979)|February 15, 2005
Genetic variation in the rate-limiting enzyme in cholesterol catabolism (cholesterol 7alpha-hydroxylase) influences the progression of atherosclerosis and risk of new clinical eventsMaaike K Hofman, Hans M G Princen, Aeilko H Zwinderman, et al.
Biomarkers in Medicine|February 3, 2012
Future potential biomarkers for postinterventional restenosis and accelerated atherosclerosisJacco C Karper, Mark M Ewing, J Wouter Jukema, et al.
The International Journal of Angiology : Official Publication of the International College of Angiology, Inc|June 11, 2015
Blood Leukocyte Count on Admission Predicts Cardiovascular Events in Patients with Acute Non-ST Elevation Myocardial InfarctionSurya Dharma, Rosmarini Hapsari, Bambang B Siswanto, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|August 7, 2007
The current status of multislice computed tomography in the diagnosis and prognosis of coronary artery diseaseJoanne D Schuijf, J Wouter Jukema, Ernest E van der Wall, et al.
Mayo Clinic Proceedings|January 7, 2020
Renal Impairment, Cardiovascular Disease, and the Short-Term Efficacy and Safety of PCSK9 Targeted by InclisiranLaurien E Zijlstra, Stella Trompet, Simon P Mooijaart, et al.
Pageof 93